Official Title
Evaluation of the Performance of a Saliva Sample Versus a Nasopharyngeal Sample in the Diagnosis of COVID-19 by RT-PCR
Brief Summary

Since December 2019, the world has faced a pandemic of COVID-19, an infectious disease caused by SARS-CoV-2, a virus that emerged in China. The reference diagnosis is based on the search for the SARS-COV-2 genome in the nasopharyngeal sample. Carrying out this sample requires the competence of a healthcare professional and presents some inconveniences for the tested patient. Because saliva collection is simple, non-invasive, painless and inexpensive, and can be performed by poorly trained personnel, it could be an alternative to the reference nasopharyngeal sample. SARS-CoV2 detection in human saliva could be a potential diagnosis of COVID infection.

Completed
SARS-COV2
RT-PCR
Saliva Collection
Nasopharyngeal Sample
Eligibility Criteria

Inclusion Criteria:

- patient hospitalized at the Amiens CHU in a COVID-19 unit

- patient seen as outpatient in the area of infectious pathologies for COVID-19
infection

Exclusion Criteria:

- Patients under 18

- patients under guardianship or curators

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

CHU Amiens
Amiens, France

Centre Hospitalier Universitaire, Amiens
NCT Number
Keywords
SARS-CoV2
RT-PCR
Saliva collection
nasopharyngeal sample